PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026
Ad hoc announcements pursuant to Art. 53 LR
Baar, 2 October 2026 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, published the invitation to its extraordinary general meeting of shareholders, which will take place on 26 October 2026, at 18.00 (CET), at Dialoghotel Eckstein in Baar.
[…]
Download PDF (German)
Download PDF (English)